Lisa Derendorf, Stephanie Stock, Dusan Simic, Arim Shukri, Christine Zelenak, Jonas Nagel, Tim Friede, Birgit Herbeck Belnap, Christoph Herrmann-Lingen, Susanne S Pedersen, Jan Sørensen, Dirk Müller And On Behalf Of The Escape Consortium
BACKGROUND: Integrated care, in particular the 'Blended Collaborative Care (BCC)' strategy, may have the potential to improve health-related quality of life (HRQoL) in multimorbid patients with heart failure (HF) and psychosocial burden at no or low additional cost. The ESCAPE trial is a randomised controlled trial for the evaluation of a BCC approach in five European countries. For the economic evaluation of alongside this trial, the four main objectives were: (i) to document the costs of delivering the intervention, (ii) to assess the running costs across study sites, (iii) to evaluate short-term cost-effectiveness and cost-utility compared to providers' usual care, and (iv) to examine the budgetary implications...
April 13, 2024: Cost Effectiveness and Resource Allocation: C/E